These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26416675)

  • 21. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 22. CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.
    Kusumbe AP; Mali AM; Bapat SA
    Stem Cells; 2009 Mar; 27(3):498-508. PubMed ID: 19253934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of small-molecule inhibitors targeting CD47.
    Yu WB; Ye ZH; Chen X; Shi JJ; Lu JJ
    Drug Discov Today; 2021 Feb; 26(2):561-568. PubMed ID: 33197622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells in human endometrium and endometrial carcinoma.
    Cervelló I; Mirantes C; Santamaria X; Dolcet X; Matias-Guiu X; Simón C
    Int J Gynecol Pathol; 2011 Jul; 30(4):317-27. PubMed ID: 21623195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the stem cell origin of cancer.
    Sell S
    Am J Pathol; 2010 Jun; 176(6):2584-494. PubMed ID: 20431026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer.
    Michaels AD; Newhook TE; Adair SJ; Morioka S; Goudreau BJ; Nagdas S; Mullen MG; Persily JB; Bullock TNJ; Slingluff CL; Ravichandran KS; Parsons JT; Bauer TW
    Clin Cancer Res; 2018 Mar; 24(6):1415-1425. PubMed ID: 29288236
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer research. Mutant stem cells may seed cancer.
    Marx J
    Science; 2003 Sep; 301(5638):1308-10. PubMed ID: 12958339
    [No Abstract]   [Full Text] [Related]  

  • 28. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
    Wang X; Wang Y; Hu J; Xu H
    Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of self-renewal in normal and cancer stem cells.
    Verga Falzacappa MV; Ronchini C; Reavie LB; Pelicci PG
    FEBS J; 2012 Oct; 279(19):3559-3572. PubMed ID: 22846222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells.
    Cheshier SH; Kalani MY; Lim M; Ailles L; Huhn SL; Weissman IL
    Neurosurgery; 2009 Aug; 65(2):237-49; discussion 249-50; quiz N6. PubMed ID: 19625901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paracrine signaling in stem cell renewal and in neoplastic tumor growth.
    Zhao C
    Sci China Life Sci; 2014 Jun; 57(6):571-4. PubMed ID: 24849510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Therapeutic Implications of Cancer Stem Cells.
    Clarke MF
    N Engl J Med; 2019 Jun; 380(23):2237-2245. PubMed ID: 31167052
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis.
    Hu T; Liu H; Liang Z; Wang F; Zhou C; Zheng X; Zhang Y; Song Y; Hu J; He X; Xiao J; King RJ; Wu X; Lan P
    Theranostics; 2020; 10(9):4056-4072. PubMed ID: 32226539
    [No Abstract]   [Full Text] [Related]  

  • 34. Stem cell origin of cancer and differentiation therapy.
    Sell S
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):1-28. PubMed ID: 15207251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinogenesis is consequence of failure of tissue development.
    Lai S
    Med Hypotheses; 2018 Oct; 119():84-87. PubMed ID: 30122497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation.
    Hendriks MAJM; Ploeg EM; Koopmans I; Britsch I; Ke X; Samplonius DF; Helfrich W
    Oncoimmunology; 2020 Sep; 9(1):1824323. PubMed ID: 33299654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance.
    Upton R; Banuelos A; Feng D; Biswas T; Kao K; McKenna K; Willingham S; Ho PY; Rosental B; Tal MC; Raveh T; Volkmer JP; Pegram MD; Weissman IL
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34257155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric stem cell division in development and cancer.
    Caussinus E; Hirth F
    Prog Mol Subcell Biol; 2007; 45():205-25. PubMed ID: 17585502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
    Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
    Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
    Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
    J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.